Dataset Information


Mechanism of human antibody-mediated neutralization of Marburg virus.

ABSTRACT: The mechanisms by which neutralizing antibodies inhibit Marburg virus (MARV) are not known. We isolated a panel of neutralizing antibodies from a human MARV survivor that bind to MARV glycoprotein (GP) and compete for binding to a single major antigenic site. Remarkably, several of the antibodies also bind to Ebola virus (EBOV) GP. Single-particle EM structures of antibody-GP complexes reveal that all of the neutralizing antibodies bind to MARV GP at or near the predicted region of the receptor-binding site. The presence of the glycan cap or mucin-like domain blocks binding of neutralizing antibodies to EBOV GP, but not to MARV GP. The data suggest that MARV-neutralizing antibodies inhibit virus by binding to infectious virions at the exposed MARV receptor-binding site, revealing a mechanism of filovirus inhibition.


PROVIDER: S-EPMC4344968 | BioStudies | 2015-01-01

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC3503067 | BioStudies
1000-01-01 | S-EPMC4635690 | BioStudies
2019-01-01 | S-EPMC6401435 | BioStudies
2020-01-01 | S-EPMC7552044 | BioStudies
2019-01-01 | S-EPMC6328579 | BioStudies
2015-01-01 | S-EPMC4344967 | BioStudies
2014-01-01 | S-EPMC4222107 | BioStudies
2018-01-01 | S-EPMC6217721 | BioStudies
1000-01-01 | S-EPMC5419075 | BioStudies
2006-01-01 | S-EPMC1346851 | BioStudies